Drug Development
Nbs update 08 24-11
LifeTech Capital Updates NeoStem (NBS) Strong Buy $4.00 Target
Don't Miss a Beat: Understanding Continuous, Real Time Physiologic Monitoring
Welcome
Ellen G. Feigal, M.D. Vice President, Research and Development
vFLIP-IKK g Blocker
Sr. Manager – Techn.Training & External Affairs Catania Site Pharmaceutical Industry & Public Research Institutions : The bridge from Science to Drugs.
